Changes in health and disease of the metalloprotease that cleaves von Willebrand factor.
about
Pathophysiology of thrombotic thrombocytopenic purpuraPathogenesis of thrombotic microangiopathiesRelevance of ADAMTS13 to liver transplantation and surgeryIs severe deficiency of ADAMTS-13 specific for thrombotic thrombocytopenic purpura? YesIs ADAMTS-13 deficiency specific for thrombotic thrombocytopenic purpura? NoHepatic stellate cell damage may lead to decreased plasma ADAMTS13 activity in ratsIncreased ADAMTS-13 proteolytic activity in rat hepatic stellate cells upon activation in vitro and in vivoADAMTS13 reduces vascular inflammation and the development of early atherosclerosis in miceThrombotic thrombocytopenic purpura in a newborn.Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias.Diagnosis of thrombotic thrombocytopenic purpura based on modulation by patient plasma of normal platelet adhesion under flow condition.A perspective on the measurement of ADAMTS13 in thrombotic thrombocytopaenic purpura.Measurement of von Willebrand factor-cleaving protease (ADAMTS-13) activity in plasma: a multicenter comparison of different assay methods.Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation: a diagnostic dilemma.The activity of the von Willebrand factor cleaving protease ADAMTS-13 in newborn infants.Deficient activity of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura.Thrombotic thrombocytopenic purpura: yesterday, today, tomorrow.von Willebrand factor cleaving protease (ADAMTS-13) and ADAMTS-13 neutralizing autoantibodies in 100 patients with thrombotic thrombocytopenic purpura.Does cryosupernatant plasma improve outcome in thrombotic thrombocytopenic purpura? No answer yet.FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay.Thrombotic thrombocytopenic purpura and its diagnosis.Molecular biology of ADAMTS13 and diagnostic utility of ADAMTS13 proteolytic activity and inhibitor assays.The pathogenicity of von Willebrand factor in thrombotic thrombocytopenic purpura: reconsideration of treatment with cryopoor plasma.Prospective study on the behaviour of the metalloprotease ADAMTS13 and of von Willebrand factor after bone marrow transplantation.Inhibitory autoantibodies against ADAMTS-13 in patients with thrombotic thrombocytopenic purpura bind ADAMTS-13 protease and may accelerate its clearance in vivo.Thrombotic thrombocytopenic purpura: survival by "giving a dam"Normal levels of ADAMTS13 and factor H are present in the pharmaceutically licensed plasma for transfusion (Octaplas) and in the universally applicable plasma (Uniplas) in development.Evaluation and management of patients with thrombotic thrombocytopenic purpura.Sporadic bloody diarrhoea-associated thrombotic thrombocytopenic purpura-haemolytic uraemic syndrome: an adult and paediatric comparison.Thrombotic thrombocytopenic purpura in systemic lupus erythematosus: risk factors and clinical outcome: a single centre study.Predictive features of severe acquired ADAMTS13 deficiency in idiopathic thrombotic microangiopathies: the French TMA reference center experienceThrombotic microangiopathies: multimers, metalloprotease, and beyond.ADAMTS13 gene mutations in children with hemolytic uremic syndrome.Idiopathic noncirrhotic intrahepatic portal hypertension is associated with sustained ADAMTS13 Deficiency.Pregnancy in type 2B VWD: a case series.[ADAMTS13, von Willebrand factor specific cleaving protease].Retrospective review of 25 cases of thrombotic thrombocytopenic purpura in Pakistan.A case of thrombotic thrombocytopenic purpura induced by acute pancreatitis.Severe dengue is associated with consumption of von Willebrand factor and its cleaving enzyme ADAMTS-13Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies.
P2860
Q24614117-9E844F37-D312-4876-A665-C8AF8A5FA6CCQ24658043-65A9F1FC-0518-4A73-B47B-46AD1AFBC10AQ28085109-28458FB1-904E-46D7-A59B-91A5ACEBB0CDQ28188189-6D769027-BB39-49BF-BE30-CA0B374146E2Q28188198-D932F198-EC79-48DD-8325-4363D1973741Q28577463-9DFAB58F-EF44-4DB1-9440-A075F2331270Q28584350-2518F588-0015-4A0A-B64D-BDB6AA41F2DEQ30511960-8A44CBF9-F49D-48C9-8E0F-ADEB0D38276FQ33346307-CE09E838-403D-4DF6-87CD-F0813372FFB8Q33346559-8B25C3D4-B412-4EF2-9E53-9E9AB342805CQ33346565-C6B12C56-5519-43F9-B800-7ABB070DE655Q33347147-C121EC1F-75D1-4E84-B569-4594D3700B0AQ33349688-774E2E31-450C-4A61-BCC8-6E226C627007Q33359551-57308795-1DEC-4538-B96F-2F0F99B3EDC6Q33359816-A7AB3CB2-02E1-46C7-A7A7-270C861C1F70Q33360049-46F70920-7D17-4D47-9A91-F4AC7973CBDAQ33361703-EB0CF8E8-4323-4B00-8AE3-8952427F065AQ33363572-40370EDC-37A6-40EF-BFDB-BF5F06EC62FAQ33365640-F5C02828-DDF2-4508-8EFE-CF6A2495140CQ33365643-43A4E954-B8C2-4B7B-B482-7BCA0BF07710Q33366296-4EFF02B5-3820-4F2C-ADA6-AB00CAE502BDQ33369765-15A41761-F68A-45C1-9DA4-BF25CA440851Q33369832-A8709D0C-DEB4-4646-943F-6933804FBD28Q33371965-F454CA1D-D7F2-41F1-8BDE-9DA4A010A61BQ33372115-3A12B3D1-9948-4700-B106-F9317F45FF22Q33373067-E8EC6B70-3A9C-4347-8E2F-7DCA62BF41A4Q33374478-FF1BBC84-C9A4-498E-8AE5-40EF6F5EAEA4Q33375004-EDD4C96D-DAF0-4BCB-A79D-41A32DC9D14EQ33379319-7370A471-E044-4911-94E0-88B7A50AD097Q33382390-33B8F347-7A33-4064-8C32-C42BC06C89BAQ33389392-3EC4329F-E6C6-4C53-99D9-228122F1C1BFQ33389435-99EA9E38-59BD-47E5-8AAE-6EF8F39A8960Q33394897-0C6F8E0D-5084-40C0-B0AC-764D9F587D9BQ33395323-2501193E-9DB6-495A-B846-BAAE33DA8AB9Q33398187-ABFAC4E9-05F7-4CFF-BB99-1F3C771F1978Q33398887-BB7FA59F-3EC2-4E77-A3B9-FB84C63D220AQ33399210-C0530B44-8441-4E12-9108-3EDEE7D29866Q33400944-D8BF8F86-5E7F-4123-B99B-DAAECA176A9DQ33401086-3C5CF9D7-250D-4F47-9C64-FC1D13577DFAQ33401403-76AC0B93-4F3A-4B4E-A38C-AEACF4BE3760
P2860
Changes in health and disease of the metalloprotease that cleaves von Willebrand factor.
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Changes in health and disease of the metalloprotease that cleaves von Willebrand factor.
@ast
Changes in health and disease of the metalloprotease that cleaves von Willebrand factor.
@en
Changes in health and disease of the metalloprotease that cleaves von Willebrand factor.
@nl
type
label
Changes in health and disease of the metalloprotease that cleaves von Willebrand factor.
@ast
Changes in health and disease of the metalloprotease that cleaves von Willebrand factor.
@en
Changes in health and disease of the metalloprotease that cleaves von Willebrand factor.
@nl
prefLabel
Changes in health and disease of the metalloprotease that cleaves von Willebrand factor.
@ast
Changes in health and disease of the metalloprotease that cleaves von Willebrand factor.
@en
Changes in health and disease of the metalloprotease that cleaves von Willebrand factor.
@nl
P2093
P356
P1433
P1476
Changes in health and disease of the metalloprotease that cleaves von Willebrand factor.
@en
P2093
P304
P356
10.1182/BLOOD.V98.9.2730
P407
P577
2001-11-01T00:00:00Z